JCI - Citations to In vivo regulation of plasminogen function by plasma carboxypeptidase B

Citations to this article

In vivo regulation of plasminogen function by plasma carboxypeptidase B

Carmen M. Swaisgood, … , Dan Eaton, Edward F. Plow

Carmen M. Swaisgood, … , Dan Eaton, Edward F. Plow

Published November 1, 2002
Citation Information: J Clin Invest. 2002;110(9):1275-1282. https://doi.org/10.1172/JCI15082.

View: Text | PDF

Article Vascular biology

Total citations by year

Year:	2024	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2007	2006	Total
Citations:	1	3	1	1	1	1	3	1	1	2	1	2	3	5	3	3	32

Citation information

Citations to this article (32)

Title and authors	Publication	Year
Identification of heparin interaction sites on thrombin-activatable fibrinolysis inhibitor that modulate plasmin-mediated activation, thermal stability, and antifibrinolytic potential Marar TT, Boffa MB	Research and Practice in Thrombosis and Haemostasis	2024
Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review M Sillen, PJ Declerck	International journal of molecular sciences	2021
Plasminogen Receptors and Fibrinolysis LA Miles, L Ny, M Wilczynska, Y Shen, T Ny, RJ Parmer	International journal of molecular sciences	2021
Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ? C Kothari, A Clemenceau, G Ouellette, K Ennour-Idrissi, A Michaud, C Diorio, F Durocher	Cancers	2021
Functions of the plasminogen receptor Plg‐R KT LA Miles, JP Vago, LP Sousa, RJ Parmer	Journal of Thrombosis and Haemostasis	2020
Plasminogen and the Plasminogen Receptor, Plg-RKT, Regulate Macrophage Phenotypic, and Functional Changes JP Vago, MA Sugimoto, KM Lima, GL Negreiros-Lima, N Baik, MM Teixeira, M Perretti, RJ Parmer, LA Miles, LP Sousa	Frontiers in immunology	2019
A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor T Stanne, M Olsson, E Lorentzen, A Pedersen, A Gummesson, A Gils, K Jood, G Engström, O Melander, P Declerck, C Jern	Thrombosis and Haemostasis	2018
Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment ZA Bazzi, J Balun, D Cavallo-Medved, LA Porter, MB Boffa	Clinical & Experimental Metastasis	2017
Deficiency of Plasminogen Receptor, Plg-RKT, Causes Defects in Plasminogen Binding and Inflammatory Macrophage Recruitment in vivo LA Miles, N Baik, S Lighvani, S Khaldoyanidi, NM Varki, H Bai, BM Mueller, RJ Parmer	Journal of Thrombosis and Haemostasis	2016
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis ZA Bazzi, D Lanoue, M El-Youssef, R Romagnuolo, J Tubman, D Cavallo-Medved, LA Porter, MB Boffa	BMC Cancer	2016
Releasing the Brakes on the Fibrinolytic System in Pulmonary EmboliClinical Perspective: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation S Singh, A Houng, GL Reed	Circulation	2016
Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer P Bouchal, M Dvořáková, T Roumeliotis, Z Bortlíček, I Ihnatová, I Procházková, JT Ho, J Maryáš, H Imrichová, E Budinská, R Vyzula, SD Garbis, B Vojtěšek, R Nenutil	Molecular & cellular proteomics : MCP	2015
New insights into the role of Plg-RKT in macrophage recruitment LA Miles, S Lighvani, N Baik, CM Parmer, S Khaldoyanidi, BM Mueller, RJ Parmer	International review of cell and molecular biology	2014
Plasminogen receptors: the first quarter century LA Miles, RJ Parmer	Seminars in thrombosis and hemostasis	2013
Fibrin Facilitates Both Innate and T Cell–Mediated Defense against Yersinia pestis D Luo, , MA Parent, I Mullarky-Kanevsky, FM Szaba, LW Kummer, DK Duso, M Tighe, J Hill, A Gruber, N Mackman, D Gailani, ST Smiley	Journal of immunology (Baltimore, Md. : 1950)	2013
The plasminogen receptor, Plg-R(KT), and macrophage function LA Miles, S Lighvani, N Baik, NM Andronicos, EI Chen, CM Parmer, S Khaldoyanidi, JE Diggs, WB Kiosses, MP Kamps, JR 3rd, RJ Parmer	Journal of Biomedicine and Biotechnology	2012
Regulation of macrophage migration by a novel plasminogen receptor Plg-RKT S Lighvani, N Baik, JE Diggs, S Khaldoyanidi, RJ Parmer, LA Miles	Blood	2011
Protective Roles for Fibrin, Tissue Factor, Plasminogen Activator Inhibitor-1, and Thrombin Activatable Fibrinolysis Inhibitor, but Not Factor XI, during Defense against the Gram-Negative Bacterium Yersinia enterocolitica D Luo, FM Szaba, LW Kummer, EF Plow, N Mackman, D Gailani, ST Smiley	Journal of immunology (Baltimore, Md. : 1950)	2011
Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation NM Andronicos, EI Chen, N Baik, H Bai, CM Parmer, WB Kiosses, MP Kamps, JR 3rd, RJ Parmer, LA Miles	Blood	2010
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke P Kraft, T Schwarz, JC Meijers, G Stoll, C Kleinschnitz, HH Schmidt	PloS one	2010
Flexibility of the Thrombin-activatable Fibrinolysis Inhibitor Pro-domain Enables Productive Binding of Protein Substrates Z Valnickova, L Sanglas, JL Arolas, SV Petersen, C Schar, D Otzen, FX Aviles, FX Gomis-Rüth, JJ Enghild	The Journal of biological chemistry	2010
L-type calcium channel blockers exert an antiinflammatory effect by suppressing expression of plasminogen receptors on macrophages R Das, T Burke, DR van Wagoner, EF Plow	Circulation research	2009
A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary culture N Okumura, T Koh, Y Hasebe, T Seki, T Ariga	The Journal of biological chemistry	2009
Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy? JL Willemse, E Heylen, ME Nesheim, DF Hendriks	Journal of Thrombosis and Haemostasis	2009
Targeted Disruption of the Gene Encoding the Murine Small Subunit of Carboxypeptidase N (CPN1) Causes Susceptibility to C5a Anaphylatoxin-Mediated Shock SL Mueller-Ortiz, D Wang, JE Morales, L Li, JY Chang, RA Wetsel	Journal of immunology (Baltimore, Md. : 1950)	2009
Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men ME Meltzer, CJ Doggen, PG de Groot, JC Meijers, FR Rosendaal, T Lisman	Haematologica	2009
Carboxypeptidase D: a novel TGF-beta target gene dysregulated in patients with lupus erythematosus NP Hoff, D Degrandi, U Hengge, K Pfeffer, JU Wurthner	Journal of Clinical Immunology	2007
Histone H2B as a functionally important plasminogen receptor on macrophages R Das, T Burke, EF Plow	Blood	2007
Plasminogen is an important regulator in the pathogenesis of a murine model of asthma CM Swaisgood, MA Aronica, S Swaidani, EF Plow	American journal of respiratory and critical care medicine	2007
Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis X Wang, PL Smith, MY Hsu, JA Tamasi, E Bird, WA Schumacher	Journal of Thrombosis and Thrombolysis	2006
Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo T Nishimura, T Myles, AM Piliposky, PN Kao, GJ Berry, LL Leung	Blood	2006
Fibrin Derived from Patients with Chronic Thromboembolic Pulmonary Hypertension Is Resistant to Lysis TA Morris, JJ Marsh, PG Chiles, WR Auger, PF Fedullo, VL Woods	American journal of respiratory and critical care medicine	2006

Advertisement